ArticleIn vivo (Athens, Greece)
Clinical Features, Prognosis, and Prognostic Factors of Remnant Gastric Cancer Patients Who Received Potentially Curative Gastrectomy.
Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
aimRemnant gastric cancer (RGC) is technically difficult for surgery due to adhesion of remnant stomach to surrounding organs. To optimize RGC treatment, it is necessary to clarify the clinical features and prognostic factors of RGC. Therefore, we aimed to clarify the clinical features and prognostic factors of RGC. PATIENTS AND
methodsThe patients were selected from the consecutive database of the Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Department of Gastric Surgery, according to the following criteria: (i) histologically-proven gastric adenocarcinoma, (ii) patients who underwent curative gastrectomy for gastric cancer as a primary treatment and archived R0 resection between 2005 and 2025. RGC is defined as GC develops at the remnant stomach after gastrectomy for benign or malignant disease.
resultsA total of 2,013 patients were eligible for the present study. In the present study, 45 patients were categorized as the RGC group, and 1,968 patients were in the non-RGC group. When comparing the patient background between RGC group and non-RGC group, significant differences were observed in median age (72 years
conclusionAlthough there are surgical, perioperative diagnosis, and tumor evaluation difficulties in RGC treatment, the survival of RGC patients was almost similar to non-RGC patients. RGC patients with lymphatic invasion were poorer than those without lymphatic invasion.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.